Exploratory study of Fuxin Tongluo Decoction in the treatment of diabetic peripheral neuropathy with Yang deficiency and cold coagulation

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100005291

Enrollment

Unknown

Registered

2021-11-05

Start date

2021-11-04

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic peripheral neuropathy

Interventions

Experimental group:Traditional Chinese medicine

Control group:Western medicine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Consistent with the diagnosis of type 2 diabetic peripheral neuropathy (2) conforming to TCM syndrome differentiation; Yang deficiency cold coagulation type; Yang-deficiency cold coagulation type was more than 10 points (3) 30-75 years old (4) Signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Exclude related neuropathy caused by other reasons, such as cervical and lumbar lesions, cerebral infarction, etc.; Various causes of nerve damage (2) patients with heart, liver and kidney dysfunction (3) using other drugs to improve peripheral neuropathy (4) pregnant or breast-feeding women or those who have pregnancy plans (5) people who are allergic to the study drugs

Design outcomes

Primary

Measure	Time frame
TCSS;	—

Secondary

Measure	Time frame
electromyography;Yang deficiency cold coagulation symptom integral;Blood sugar;	—

Countries

China

Contacts

Public ContactJiang min zi Li

lijiangminzi@163.com13720039639

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026